- BNF:
- 2.3.2
- Status:
- Amber
- Decision Date:
- November 2017
Comments
See shared care guideline for the maintenance of sinus rhythm after successful cardioversion. (Decision date - November 2017).
Be aware of MHRA warnings
Amber Drug Classifications
- 2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable
search again